Eric Benevich

Chief Commercial Officer, Neurocrine Biosciences

Bought, 12 months

$0.0M

Sold, 12 months

$1.2M

Companies

Latest trade

Sep 9, 2026

Companies

Neurocrine BiosciencesChief Commercial Officer −$1.2M

Trades

NBIX Sold 2,154 shares at $154.61 · planned $0.3M Sep 9

NBIX Sold 5,970 shares at $151.74 · planned $0.9M Nov 28

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.